STAT+: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed
STAT
JANUARY 18, 2024
Pear received Food and Drug Administration clearance for its app treating substance use disorders and insomnia but insurers mostly refused to cover the novel treatments. The bankruptcy of Pear Therapeutics last year proved that selling software-based treatments like drugs is harder than anticipated.
Let's personalize your content